基本資料
種類: ETF
費用比率%: --
資產淨值: 27.54
成立日期: 01/06/2026
 
分析
市值分佈:
79.19%
大市值
7.25%
中市值
9.22%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 14/11/2026 05:09) 總持有投資項目: 37  
0%
 
100%
     10大 (30.45%)
代號 名稱 佔比% ▼ 持有日期
SUPNSupernus Inc2.5830/10/2026
BTSGBrightSpring Health Services2.5830/09/2026
NURPFNeuren Pharmaceuticals Ltd.2.5430/10/2026
HLBBFH. Lundbeck A/S2.5430/09/2026
LRNStride2.5330/09/2026
BMYBristol-Myers Squibb Co2.5230/10/2026
LOPEGrand Canyon Education2.5130/10/2026
IPSEFIpsen S.A.2.4930/10/2026
DFTXDefinium Therapeutics Inc2.4830/10/2026
JAZZJazz Pharmaceuticals plc2.3330/10/2026
BMRNBioMarin Pharmaceutical2.3030/10/2026
BFAMBright Horizons Family Solutions2.2030/10/2026
BWAYBrainsway Ltd.2.1030/10/2026
VNDAVanda Pharmaceuticals1.9430/10/2026
ACADACADIA Pharmaceuticals1.9130/10/2026
MPLTMapLight Therapeutics Inc.1.4230/10/2026
AVXLAnavex Life Sciences Corp1.1530/10/2026
  1   2  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.